US$ 25.55
glp-1 for crohn's Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology Frontiers | GLP-1 receptor agonists
Description
Real patients

10.1073/pnas.84.20.7005

Cells 2019 , 8 , 589
However, recent research based on human clinical data is providing much more reassuring evidence about the safety profile of these medications

Some European countries have more room within their budgets to provide such coverage than others
